Association of colorectal carcinoma and metabolic syndrome.


Journal

Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina
ISSN: 1840-2445
Titre abrégé: Med Glas (Zenica)
Pays: Bosnia and Herzegovina
ID NLM: 101250177

Informations de publication

Date de publication:
01 Feb 2020
Historique:
received: 09 09 2019
revised: 04 11 2019
accepted: 14 11 2019
pubmed: 18 12 2019
medline: 25 6 2021
entrez: 18 12 2019
Statut: ppublish

Résumé

Aim Colorectal carcinoma is one of the most common neoplasms, especially in Western countries and those with westernisation. On the other hand, high rate of metabolic syndrome (MetSy) has also been noticed, as well as in Western countries. It seems like these two conditions are somehow connected. In this study, we wish to explore some characteristics of colorectal carcinoma and its correlation with MetSy. Methods In this retrospective study the data were taken from medical records of 67 patients with colorectal carcinoma, and for 30 healthy controls. Input parameters of patients were compared mutually, as well as with parameters of healthy, control examinees that had negative screening colonoscopy for neoplasm. Results Average age of patients was 68 years. The most frequent localisation of neoplasm was on rectum (53.7%) and most frequent level was Dukes C (38.8%). The patients had MetSy more frequently when compared with controls (p=0.048), and also they had more MetSy components (p=0.006). The link between MetSy and localisation of neoplasm was not found, neither with its pathohystological characteristics. Conclusion Patients with MetSy should be warned about the increased risk of colorectal carcinoma, and, in this way, motivated for earlier and more frequent screening colonoscopies, as well as of a change of unhealthy lifestyle.

Identifiants

pubmed: 31845566
doi: 10.17392/1079-20
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-157

Informations de copyright

Copyright© by the Medical Assotiation of Zenica-Doboj Canton.

Auteurs

Josip Lesko (J)

Department of Ear, Nose and Throat Surgery; University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina.

Pejana Rastović (P)

Health Centre Mostar, Mostar, Bosnia and Herzegovina.

Anđela Azinović (A)

Health Centre Mostar, Mostar, Bosnia and Herzegovina.

Sanja Ðurasović (S)

Department of Internal Diseases, University Clinical Hospital, Mostar, Bosnia and Herzegovina.

Ante Bogut (A)

Department of Psychiatry, University Clinical Hospital, Mostar, Bosnia and Herzegovina.

Jelena Zovko (J)

Department of Psychiatry, University Clinical Hospital, Mostar, Bosnia and Herzegovina.

Marko Pavlović (M)

School of Medicine, University Mostar, Mostar, Bosnia and Herzegovina.

Zdenka Zovko (Z)

School of Medicine, University Mostar, Mostar, Bosnia and Herzegovina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH